A multistate outbreak of Salmonella enteritidis in June 2025, linked to contaminated eggs from a California facility, led to 79 cases and a major recall. The incident underscores the critical role of ...

SK Biopharmaceuticals signed a memorandum of understanding with PhnyX Lab, a U.S.-based AI startup backed by SK Networks, to ...

Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products with the dyes. The move comes nearly two months after U.S. health officials ...

Following the inspection, the USFDA issued a Form 483 containing five observations. The company clarified that all the ...

WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as ...

A patient in Angola was the first in a groundbreaking human clinical trial approved by the U.S. Food and Drug Administration ...

Kraft Heinz announced that it plans to remove all synthetic food dyes from its U.S. product portfolio by the end of 2027.

The FDA announced a new fast-track approval program for domestic drug developers for projects that are national priorities.

FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.